MyLam
Lam Research Corporation Announces Financial Results for the Quarter Ended December 26, 2010
January 26, 2011

FREMONT, Calif.--(BUSINESS WIRE)-- Lam Research Corporation (NASDAQ: LRCX) highlights for the December 2010 quarter were:

Lam Research Corporation
Financial Highlights for the Quarter Ended December 26, 2010
(in thousands, except per share data and percentages)
         
    U.S. GAAP   Ongoing
         
• Revenue:   $ 870,714     $ 870,714  
         
• Operating Margin:     27.7 %     27.7 %
         
• Net Income:   $ 221,856     $ 217,093  
         
• Diluted EPS:   $ 1.78     $ 1.74  
                 
 

Lam Research Corporation today announced financial results for the quarter ended December 26, 2010. Revenue for the period was $870.7 million, gross margin was $407.4 million (46.8%), and net income was $221.9 million, or $1.78 per diluted share, compared to revenue of $805.9 million, gross margin of $377.3 million (46.8%), and net income of $193.7 million, or $1.55 per diluted share, for the September 2010 quarter. Shipments for the December 2010 quarter were $892 million compared to $808 million during the September 2010 quarter.

The Company's ongoing results for the December 2010 quarter exclude certain benefits for research and development tax credits. The Company's ongoing results for the September 2010 quarter exclude certain benefits for restructuring activities and asset impairments. Management uses the presentation of ongoing operating income, ongoing operating expenses, ongoing operating margin, ongoing net income, and ongoing net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of ongoing results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing the investor's ability to view the Company's results from management's perspective. A table presenting a reconciliation of ongoing net income, ongoing operating income, ongoing operating expenses, and ongoing operating margin results to results under U.S. GAAP is included at the end of this press release and on the Company's web site at http://investor.lamrc.com.

Ongoing net income was $217.1 million, or $1.74 per diluted share in the December 2010 quarter compared to ongoing net income of $190.6 million, or $1.52 per diluted share, for the September 2010 quarter. Ongoing operating expenses for the December 2010 quarter were $166.3 million compared with the September 2010 quarter of $158.5 million. This change is primarily due to increased research and development activities and enhanced levels of sales and marketing expense associated with customer joint development projects.

The geographic distribution of shipments and revenue during the December 2010 quarter is shown in the following table:

Region   Shipments   Revenue
North America   11 %   6 %
Europe   13 %   13 %
Japan   10 %   11 %
Korea   18 %   18 %
Taiwan   29 %   38 %
Asia Pacific   19 %   14 %
         
 

Cash and cash equivalents, short-term investments and restricted cash and investments balances were $1.2 billion at the end of the December 2010 quarter, compared to $1.1 billion at the end of the September 2010 quarter. Cash flows from operating activities were approximately $185.6 million during the December 2010 quarter. Deferred revenue and deferred profit balances at the end of the December 2010 quarter were $222.9 million and $135.1 million, respectively. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $47.7 million as of December 26, 2010.

"Lam delivered record shipments, revenues and earnings per share for the December quarter. In calendar year 2010, our system shipments grew by nearly 200%, significantly outperforming the 120% growth in wafer fab equipment spending and leading to record levels of revenue and earnings at $3 billion and $5.35 per share respectively," stated Steve Newberry, chief executive officer and vice chairman of the board. "Our performance reflects the strong market share gains we achieved in 2010 across both etch and clean product lines. Looking ahead, we are focused on further strengthening our market positions by increasing our investments in field-based customer technology and productivity solutions, as well as core R&D programs targeted at meeting our customers' future technology needs."

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate, but are not limited, to the anticipated revenue from shipments to Japanese customers; our anticipated continued investments in field-based customer technology and productivity solutions as well as our core R&D programs, our ability to meet customers' future technology needs and our future market position. Some factors that may affect these forward-looking statements include: business conditions in the semiconductor industry and the overall economy; the strength of the financial performance of our existing and prospective customers; the introduction of new and innovative technologies; the occurrence and pace of technology transitions and conversions; the actions of our competitors, consumers, semiconductor companies and key suppliers and subcontractors; and the success of research and development and sales and marketing programs. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed by us with the Securities and Exchange Commission, including specifically our report on Form 10-K for the year ended June 27, 2010 and the report on Form 10-Q for the three months ended September 26, 2010. These uncertainties and changes could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world's semiconductor industry. Lam's common stock trades on The NASDAQ Global Select Market SM under the symbol LRCX. Lam is a NASDAQ-100® company. For more information, visit www.lamresearch.com.

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data and percentages)
(unaudited)
                     
    Three Months Ended   Six Months Ended
    December 26,   September 26,   December 27,   December 26,   December 27,
    2010   2010   2009   2010   2009
Revenue   $ 870,714     $ 805,874     $ 487,176     $ 1,676,588     $ 805,724  
Cost of goods sold     463,281       428,548       268,685       891,829       455,918  
Cost of goods sold - 409A expense     -       -       (2,696 )     -       (5,816 )
Total costs of goods sold     463,281       428,548       265,989       891,829       450,102  
Gross margin     407,433       377,326       221,187       784,759       355,622  
Gross margin as a percent of revenue     46.8 %     46.8 %     45.4 %     46.8 %     44.1 %
Research and development     90,477       86,353       82,171       176,830       153,370  
Selling, general and administrative     75,852       72,142       60,111       147,994       112,230  
Restructuring and asset impairments     -       (5,163 )     5,919       (5,163 )     8,012  
409A expense     -       -       (18,362 )     -       (38,590 )
Total operating expenses     166,329       153,332       129,839       319,661       235,022  
Operating income     241,104       223,994       91,348       465,098       120,600  
Operating margin as a percent of revenue     27.7 %     27.8 %     18.8 %     27.7 %     15.0 %
Other income (expense), net     1,038       (979 )     (58 )     59       (426 )
Income before income taxes     242,142       223,015       91,290       465,157       120,174  
Income tax expense     20,286       29,291       21,716       49,577       33,803  
Net income   $ 221,856     $ 193,724     $ 69,574     $ 415,580     $ 86,371  
Net income per share:                    
Basic net income per share   $ 1.80     $ 1.57     $ 0.55     $ 3.37     $ 0.68  
Diluted net income per share   $ 1.78     $ 1.55     $ 0.54     $ 3.32     $ 0.67  
Number of shares used in per share calculations:                    
Basic     123,101       123,665       127,296       123,384       127,035  
Diluted     124,786       125,202       128,829       124,999       128,389  
                     
 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
             
    December 26,   September 26,   June 27,
    2010   2010   2010
    (unaudited)   (unaudited)   (1)
ASSETS            
Cash and cash equivalents   $ 729,060   $ 628,281   $ 545,767  
Short-term investments     303,038     304,992     280,690  
Accounts receivable, net     689,400     526,904     499,890  
Inventories     333,874     338,335     318,479  
Deferred income taxes     47,380     46,191     46,158  
Other current assets     76,993     74,728     65,677  
Total current assets     2,179,745     1,919,431     1,756,661  
Property and equipment, net     229,769     206,238     200,336  
Restricted cash and investments     165,244     165,244     165,234  
Deferred income taxes     28,030     26,968     26,218  
Goodwill and intangible assets     225,671     231,688     236,906  
Other assets     104,758     102,727     102,037  
Total assets   $ 2,933,217   $ 2,652,296   $ 2,487,392  
             
LIABILITIES AND STOCKHOLDERS' EQUITY            
Current liabilities   $ 689,871   $ 612,397   $ 558,657  
             
Long-term debt and capital leases   $ 16,524   $ 15,077   $ 17,645  
Income taxes payable     118,323     114,946     110,462  
Other long-term liabilities     23,720     23,248     32,493  
Stockholders' equity     2,084,779     1,886,628     1,768,135  
Total liabilities and stockholders' equity   $ 2,933,217   $ 2,652,296   $ 2,487,392  
             
1 Derived from audited financial statements
             
 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
                     
    Three Months Ended   Six Months Ended
    December 26,   September 26,   December 27,   December 26,   December 27,
    2010   2010   2009   2010   2009
CASH FLOWS FROM OPERATING ACTIVITIES:                    
Net income   $ 221,856     $ 193,724     $ 69,574     $ 415,580     $ 86,371  

Adjustments to reconcile net income to net cash provided by (used for) operating activities:

                   
Depreciation and amortization     18,663       17,948       18,184       36,611       35,865  
Deferred income taxes     (3,039 )     (783 )     9,229       (3,822 )     21,711  
Restructuring charges, net     -       (5,163 )     5,919       (5,163 )     8,012  
Equity-based compensation expense     12,759       13,009       13,259       25,768       27,217  
Income tax benefit on equity-based compensation plans     (918 )     5,083       303       4,165       214  
Excess tax benefit on equity-based compensation plans     711       (3,939 )     (235 )     (3,228 )     (603 )
Other, net     (1,600 )     (1,964 )     173       (3,564 )     1,332  
Changes in operating assets and liabilities:     (62,849 )     37,829       (43,096 )     (25,020 )     (104,105 )
Net cash provided by operating activities     185,583       255,744       73,310       441,327       76,014  
                     
CASH FLOWS FROM INVESTING ACTIVITIES:                    
Capital expenditures and intangible assets     (38,025 )     (19,130 )     (6,893 )     (57,155 )     (12,725 )
Net sales/maturities (purchases) of available-for-sale securities     (1,160 )     (24,506 )     (1,016 )     (25,666 )     (10,791 )
Purchase of other investments     -       -       -       -       (961 )
Proceeds from sale of assets     1,544       -       -       1,544       -  
Transfer of restricted cash and investments     -       (10 )     97       (10 )     (6,474 )
Net cash used for investing activities     (37,641 )     (43,646 )     (7,812 )     (81,287 )     (30,951 )
                     
CASH FLOWS FROM FINANCING ACTIVITIES:                    
Principal payments on long-term debt and capital lease obligations     (78 )     (3,333 )     (689 )     (3,411 )     (2,604 )
Net proceeds from issuance of long-term debt     -       -       52       -       336  
Excess tax benefit on equity-based compensation plans     (711 )     3,939       235       3,228       603  
Cash paid in advance for stock repurchase contracts     (50,000 )     -       -       (50,000 )     -  
Treasury stock purchases     (4,151 )     (144,795 )     (576 )     (148,946 )     (2,932 )
Reissuances of treasury stock     -       7,155       -       7,155       5,761  
Proceeds from issuance of common stock     3,407       835       4,126       4,242       6,382  
Net cash provided by (used for) financing activities     (51,533 )     (136,199 )     3,148       (187,732 )     7,546  
Effect of exchange rate changes on cash     4,370       6,615       357       10,985       3,390  
Net increase in cash and cash equivalents     100,779       82,514       69,003       183,293       55,999  
Cash and cash equivalents at beginning of period     628,281       545,767       361,163       545,767       374,167  
Cash and cash equivalents at end of period   $ 729,060     $ 628,281     $ 430,166     $ 729,060     $ 430,166  
                     
 
Reconciliation of U.S. GAAP Net Income to Ongoing Net Income
(in thousands, except per share data)
(unaudited)
         
    Three Months Ended   Three Months Ended
    December 26,   September 26,
    2010   2010
U.S. GAAP net income   $ 221,856     $ 193,724  
Pre-tax non-ongoing items:        
Restructuring and asset impairments - operating expenses     -       (5,163 )
Net tax expense on non-ongoing item     -       2,061  
Net tax benefit of R&D credit     (4,763 )     -  
Ongoing net income   $ 217,093     $ 190,622  
Ongoing net income per diluted share   $ 1.74     $ 1.52  
Number of shares used for diluted per share calculation     124,786       125,202  
         
         

Reconciliation of U.S. GAAP Operating Expenses and Operating Income to Ongoing Operating Expenses and Operating Income

(in thousands, except percentages)
(unaudited)
         
    Three Months Ended   Three Months Ended
    December 26,   September 26,
    2010   2010
U.S. GAAP gross margin   $ 407,433     $ 377,326  
         
U.S. GAAP operating expenses   $ 166,329     $ 153,332  
Pre-tax non-ongoing items:        
Restructuring and asset impairments - operating expenses     -       5,163  
Ongoing operating expenses   $ 166,329     $ 158,495  
Ongoing operating income   $ 241,104     $ 218,831  
Ongoing operating margin as a percent of revenue     27.7 %     27.2 %
                 
 
Reconciliation of U.S. GAAP Earnings to Ongoing Earnings Per Share
(in thousands, except per share data)
(unaudited)
     
    Twelve Months Ended
    December 26,
    2010
U.S. GAAP net income   $ 675,878  
Pre-tax non-ongoing items:    
Restructuring and asset impairments - cost of goods sold     3,438  
Restructuring and asset impairments - operating expenses     8,139  
Net tax expense on non-ongoing items     (5,606 )
Net tax benefit of R&D credit     (4,763 )
Ongoing net income   $ 677,086  
Ongoing net income per diluted share   $ 5.35  
Number of shares used for diluted per share calculation*     126,590  
     
 

* Shares for twelve months ended December 26, 2010 calculated using diluted share count for March through December 2010 quarters divided by four.

Lam Research Corporation
Shanye Hudson, 510-572-4589
Director, Investor Relations
shanye.hudson@lamresearch.com

Source: Lam Research Corporation

 

News Provided by Acquire Media

circle-arrow2circle-arrow2facebookgooglehandshake2health2linkedinmenupdfplant2searchtwitteryoutube